XBIT · XBiotech
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Market Cap
56.4M
52 Wk Range
$1.80 - $2.73
Previous Close
$1.85
Open
$1.86
Volume
62,580
Day Range
$1.78 - $1.87
Enterprise Value
-106M
Cash
105M
Avg Qtr Burn
-4.521M
Insider Ownership
38.08%
Institutional Own.
6.72%
Qtr Updated
Sep 30th 2026
